HealthEquity Total Liabilities 2014-2025 | HQY
HealthEquity total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- HealthEquity total liabilities for the quarter ending April 30, 2025 were $1.292B, a 12.52% increase year-over-year.
- HealthEquity total liabilities for 2025 were $1.334B, a 18.15% increase from 2024.
- HealthEquity total liabilities for 2024 were $1.129B, a 5.4% decline from 2023.
- HealthEquity total liabilities for 2023 were $1.193B, a 4.88% decline from 2022.
| HealthEquity Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $1,334 |
| 2024 | $1,129 |
| 2023 | $1,193 |
| 2022 | $1,255 |
| 2021 | $1,332 |
| 2020 | $1,535 |
| 2019 | $33 |
| 2018 | $23 |
| 2017 | $17 |
| 2016 | $16 |
| 2015 | $15 |
| 2014 | $68 |
| 2013 | $53 |
| HealthEquity Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-04-30 | $1,292 |
| 2025-01-31 | $1,334 |
| 2024-10-31 | $1,364 |
| 2024-07-31 | $1,357 |
| 2024-04-30 | $1,149 |
| 2024-01-31 | $1,129 |
| 2023-10-31 | $1,106 |
| 2023-07-31 | $1,117 |
| 2023-04-30 | $1,116 |
| 2023-01-31 | $1,193 |
| 2022-10-31 | $1,182 |
| 2022-07-31 | $1,209 |
| 2022-04-30 | $1,210 |
| 2022-01-31 | $1,255 |
| 2021-10-31 | $1,228 |
| 2021-07-31 | $1,286 |
| 2021-04-30 | $1,314 |
| 2021-01-31 | $1,332 |
| 2020-10-31 | $1,302 |
| 2020-07-31 | $1,324 |
| 2020-04-30 | $1,522 |
| 2020-01-31 | $1,535 |
| 2019-10-31 | $1,542 |
| 2019-07-31 | $81 |
| 2019-04-30 | $67 |
| 2019-01-31 | $33 |
| 2018-10-31 | $21 |
| 2018-07-31 | $22 |
| 2018-04-30 | $21 |
| 2018-01-31 | $23 |
| 2017-10-31 | $22 |
| 2017-07-31 | $15 |
| 2017-04-30 | $12 |
| 2017-01-31 | $17 |
| 2016-10-31 | $12 |
| 2016-07-31 | $11 |
| 2016-04-30 | $10 |
| 2016-01-31 | $16 |
| 2015-10-31 | $14 |
| 2015-07-31 | $12 |
| 2015-04-30 | $11 |
| 2015-01-31 | $15 |
| 2014-10-31 | $12 |
| 2014-07-31 | $55 |
| 2014-04-30 | $0 |
| 2014-01-31 | |
| 2013-10-31 | $0 |
| 2013-07-31 | $0 |
| 2013-01-31 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.395B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.596B | 25.24 |
| CVS Health (CVS) | United States | $77.976B | 9.69 |
| Elevance Health (ELV) | United States | $62.251B | 8.37 |
| Cencora (COR) | United States | $56.726B | 19.74 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $20.342B | 16.50 |
| Natera (NTRA) | United States | $19.203B | 0.00 |
| BioMerieux (BMXMF) | France | $16.276B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.050B | 0.00 |
| Solventum (SOLV) | United States | $12.516B | 13.25 |
| ICON (ICLR) | Ireland | $11.276B | 10.48 |
| Revvity (RVTY) | United States | $10.693B | 18.40 |
| Viatris (VTRS) | United States | $10.446B | 3.59 |
| Medpace Holdings (MEDP) | United States | $8.878B | 22.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.792B | 0.00 |
| Avantor (AVTR) | United States | $8.409B | 12.22 |
| Charles River Laboratories (CRL) | United States | $7.357B | 14.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.197B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.928B | 29.02 |
| BrightSpring Health Services (BTSG) | United States | $3.465B | 31.79 |
| Sotera Health (SHC) | United States | $3.125B | 17.76 |
| Surgery Partners (SGRY) | United States | $2.866B | 37.27 |
| Concentras Parent (CON) | United States | $2.557B | 14.78 |
| Alignment Healthcare (ALHC) | United States | $2.473B | 0.00 |
| Organon (OGN) | United States | $2.457B | 2.61 |
| GeneDx Holdings (WGS) | United States | $2.235B | 86.09 |
| Progyny (PGNY) | United States | $1.966B | 43.28 |
| PACS (PACS) | United States | $1.771B | 0.00 |
| Premier (PINC) | United States | $1.723B | 13.08 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Ardent Health (ARDT) | United States | $1.566B | 6.68 |
| Teladoc Health (TDOC) | United States | $1.461B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.232B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.086B | 8.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.886B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.711B | 6.66 |
| CareDx (CDNA) | United States | $0.710B | 11.09 |
| Nutex Health (NUTX) | United States | $0.618B | 9.35 |
| Embecta (EMBC) | United States | $0.601B | 4.05 |
| So-Young (SY) | China | $0.581B | 0.00 |
| SBC Medicals (SBC) | United States | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| LifeMD (LFMD) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.149B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |